Pancreatic Cancer Research

ResearcherShandong UniversityActive in the last 2 years

Xin Zhang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-2138-5600; OpenAlex author ID A5100327584. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: 1 paper · 2023: none · 2024: none · 2025: 1 paper

Papers 3

  1. CHMP4C promotes pancreatic cancer progression by inhibiting necroptosis via the RIPK1/RIPK3/MLKL pathway. Last author DOI 10.1016/j.jare.2025.01.040↗
  2. A panel of necroptosis-related genes predicts the prognosis of pancreatic adenocarcinoma. Last author DOI 10.1016/j.tranon.2022.101462↗
  3. The association between dietary vitamin A intake and pancreatic cancer risk: a meta-analysis of 11 studies. Co-author DOI 10.1042/bsr20160341↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Longchen Yu · 1 shared paper, 2025 · strength 0.27
  2. Lei Wang · 1 shared paper, 2025 · strength 0.27
  3. Zheng-Dong Luo · 1 shared paper, 2022 · strength 0.15
  4. Lei Wang · 1 shared paper, 2022 · strength 0.15
  5. Shuguang Zhang · 1 shared paper, 2016 · strength 0.06
  6. Hongqiang Chen · 1 shared paper, 2016 · strength 0.06
  7. Tao Zhang · 1 shared paper, 2016 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.